QA: Provectus Biopharmaceuticals INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000315545_2012_Provectus_Biopharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000315545, Provectus Biopharmaceuticals INC

  xvar xval
0 AssetsCurrent 7,705,773
1 IntangibleAssetsNetIncludingGoodwill 5,597,068
2 PropertyPlantAndEquipmentNet 20,111
3 remainder_Assets 27,000
4 LiabilitiesCurrent 262,724
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,067,488
7 CostOfGoodsAndServicesSold 15,216
8 SellingGeneralAndAdministrativeExpense 57,524,849
9 ResearchAndDevelopmentExpense 38,093,394
10 remainder_Expenses 14,216,381
11 remainder_Revenues 39,757
12 remainder_NetIncome 4,025,361
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 13,349,952
1 Liabilities 3,330,212
2 Expenses 109,849,840
3 Revenues 39,757
4 StockholdersEquity 10,019,740
5 NetIncome -105,784,722
6 ComprehensiveNetIncome -105,784,722
7 BaseVar 65,297,561
8 EconomicCapitalRatiobeforeLimitedLiability -10.1
9 EconomicCapitalRatio 0.000426

Edgar->Model Mapping

Feature Distribution